Series date: 
04/01/2024 - 12:15pm MDT to 12/31/2026 - 1:15pm MST

Activity Description:

The Grand Rounds Series aims to offer its audience a wide variety of topics from a diverse group of speakers to not only help them remain current on the latest advances in medicine, but to also assist them as they continue to grow professionally. OB/GYN grand rounds are an integral component of medical education, teaching new information and enhancing clinical reasoning skills. Topics and speakers are selected to provide clinical providers with up-to-date knowledge about timely issues in Obstetrics and Gynecology. We enthusiastically invite you to join our integrated knowledge network in this education activity designed to keep practitioners up-to-date on important areas of OB/GYN medicine. 

Target Audience:

Physicians/Residents/Medical Students/Clinical Staff

Learning Objectives:

  • Identify the indications and contraindications for new modalities in the prevention, diagnosis, and treatment of OB/GYN conditions.
  • Formulate prioritized differential diagnoses for the clinical presentations of specific medical conditions, diagnoses, and diseases.
  • Apply clinical guidelines to patients under their care with an understanding of the rationale behind the guidelines and the expected outcomes of specific medical conditions, diagnoses, diseases.
  • Integrate research techniques related to specific medical conditions, diagnoses, and diseases, into their own clinical, translational or basic science research.

Moderator:

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.00 AMA PRA Category 1TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose. 

Series location: 
HCA HealthONE Rose
4567 E 9th Ave
Denver, CO 80220
United States

Sessions

Session Date
Syphilis Updates 05/07/2024 - 12:15pm to 1:15pm MDT